Senior Machine Learning Engineer
Amgen
Senior Machine Learning Engineer
Amgen
Makes biotech medicines for serious illnesses
ABOUT AMGEN
Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We discover, develop, manufacture and deliver innovative medicines to help millions of patients. Amgen helped establish the biotechnology industry more than 40 years ago and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today.
ABOUT THE ROLE
We are seeking a Senior Machine Learning Engineer, Forecasting to join the Forecasting team within the AI & Data organization. This role will design, build, deploy, and maintain scalable machine learning systems that power forecasting capabilities and uncertainty-aware decision support across the company.
This senior member of the team will work cross-functionally to translate advanced forecasting methods into reliable, production-grade solutions that support critical business processes and help Amgen deliver on its “every patient, every time” mandate. The role is particularly well suited to a strong engineer who is excited about building robust ML infrastructure, productionizing state-of-the-art forecasting models, and enabling decision-support solutions that inform multi-horizon planning and business decision-making.
Key Responsibilities
Basic Qualifications
Preferred Qualifications
EQUAL OPPORTUNITY STATEMENT
Amgen is an Equal Opportunity employer and will consider you without regard to your race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, or disability status.
We will ensure that individuals with disabilities are provided with reasonable accommodation to participate in the job application or interview process, to perform essential job functions, and to receive other benefits and privileges of employment. Please contact us to request an accommodation.
.Amgen develops and makes biologic medicines, which are drugs built from proteins and antibodies grown in living cells, for serious conditions such as heart disease, cancer, and bone loss. Its anemia drug Epogen, approved in 1989, became one of the biotechnology industry's first blockbuster medicines. Amgen grows these drugs in large tanks called bioreactors, and its products include the cholesterol drug Repatha, the bone-building drug Evenity, and the severe asthma drug Tezspire. It earns money by selling these medicines, mostly through large drug wholesalers that supply hospitals and pharmacies. Amgen was founded in 1980 and is based in Thousand Oaks, California.
Explore more opportunities at Amgen